Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S. - I., et al. (2016). Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid, 23(4), 209 - 213.

Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S. - I., et al. (2012). Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid, 19(4), 167 - 170.

Jesus, C. S. H., Vaz, D. C., Saraiva, M. J. M., & Brito, R. M. M. (2012). The V30M amyloidogenic mutation decreases the rate of refolding kinetics of the tetrameric protein transthyretin. Spectroscopy (Netherlands), 27(5-6), 343 - 348.

Munar-Qués, M., Masjuan, J., Coelho, T., Moreira, P., et al. (2007). Familial amyloid polyneuropathy associated with TTRSer50Arg mutation in two Iberian families presenting a novel single base change in the mutant gene. Amyloid, 14(2), 147 - 152.

Munar-Qués, M., Saraiva, M. J. M., Viader-Farré, C., Zabay-Becerril, J. M., & Mulet-Ferrer, J. (2005). Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid, 12(1), 54 - 61.

Dolado, I., Nieto, J., Saraiva, M. J. M., Arsequell, G., et al. (2005). Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors. Journal of Combinatorial Chemistry, 7(2), 246 - 252.

Altland, K., Winter, P., Saraiva, M. J. M., & Suhr, O. (2004). Sulfite and base for the treatment of familial amyloidotic polyneuropathy: Two additive approaches to stabilize the conformation of human amyloidogenic transthyretin. Neurogenetics, 5(1), 61 - 67.